Mycetoma caused by Madurella mycetomatis:: a neglected infectious burden

被引:175
作者
Ahmed, AOA
van Leeuwen, W
Fahal, A
van de Sande, W
Verbrugh, H
van Belkum, A
机构
[1] Erasmus MC, Dept Med Microbiol & Infect Dis, NL-3015 GD Rotterdam, Netherlands
[2] Univ Khartoum, Inst Enderm Dis, Khartoum, Sudan
[3] Univ Khartoum, Mycetoma Clin, Khartoum, Sudan
关键词
D O I
10.1016/S1473-3099(04)01131-4
中图分类号
R51 [传染病];
学科分类号
100401 ;
摘要
Tropical eumycetoma is frequently caused by the fungus Madurella mycetomatis. The disease is characterised by extensive subcutaneous masses, usually with sinuses draining pus, blood, and fungal grains. The disease affects individuals of all ages, although disability is most severe in adults who work outdoors. Compared with major diseases such as tuberculosis, malaria, and HIV, disease from M mycetomatis is underestimated but socioeconomically important. Many scientific case reports on mycetoma exist, but fundamental research was lacking until recently. We present a review on developments in the clinical, epidemiological, and diagnostic management of M mycetomatis eumycetoma. We describe newly developed molecular diagnostic and gene typing procedures, and their application for management of patients and environmental research. Fungal susceptibility tests have been developed as well as a mouse model of infection. These advances should greatly further our understanding of the molecular basis of eumycetoma.
引用
收藏
页码:566 / 574
页数:9
相关论文
共 97 条
  • [1] ABBOTT P., 1956, TRANS ROY SOC TROP MED AND HYG, V50, P11, DOI 10.1016/0035-9203(56)90004-9
  • [2] AGARWAL SC, 1985, TROP GEOGR MED, V37, P133
  • [3] Madurella mycetomatis strains from mycetoma lesions in Sudanese patients are clonal
    Ahmed, A
    van de Sande, W
    Verbrugh, H
    Fahal, A
    van Belkum, A
    [J]. JOURNAL OF CLINICAL MICROBIOLOGY, 2003, 41 (10) : 4537 - 4541
  • [4] Environmental occurrence of Madurella mycetomatis, the major agent of human eumycetoma in Sudan
    Ahmed, A
    Adelmann, D
    Fahal, A
    Verbrugh, H
    van Belkum, A
    de Hoog, S
    [J]. JOURNAL OF CLINICAL MICROBIOLOGY, 2002, 40 (03) : 1031 - 1036
  • [5] A murine model of Madurella mycetomatis eumycetoma
    Ahmed, AO
    van Vianen, W
    ten Kate, MT
    van de Sande, WWJ
    van Belkum, A
    Fahal, AH
    Verbrugh, HA
    Bakker-Woudenberg, IAJM
    [J]. FEMS IMMUNOLOGY AND MEDICAL MICROBIOLOGY, 2003, 37 (01): : 29 - 36
  • [6] In vitro susceptibilities of Madurella mycetomatis to itraconazole and amphotericin B assessed by a modified NCCLS method and a viability-based 2,3-Bis(2-methoxy-4-nitro-5-[sulfophenyl)-5-[(phenylamino)carbonyl]-2H-tetrazolium hydroxide (XTT) assay
    Ahmed, AOA
    van de Sande, WWJ
    van Vianen, W
    van Belkum, A
    Fahal, AH
    Verbrugh, HA
    Bakker-Woudenberg, IAJM
    [J]. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2004, 48 (07) : 2742 - 2746
  • [7] Molecular detection and identification of agents of eumycetoma: Detailed report of two cases
    Ahmed, AOA
    Desplaces, N
    Leonard, P
    Goldstein, F
    De Hoog, S
    Verbrugh, H
    van Belkum, A
    [J]. JOURNAL OF CLINICAL MICROBIOLOGY, 2003, 41 (12) : 5813 - 5816
  • [8] Development of a species-specific PCR-restriction fragment length polymorphism analysis procedure for identification of Madurella mycetomatis
    Ahmed, AOA
    Mukhtar, MM
    Kools-Sijmons, M
    Fahal, AH
    de Hoog, S
    Van den Ende, BG
    Zijlstra, EE
    Verbrugh, H
    Abugroun, ESAM
    Elhassan, AM
    van Belkum, A
    [J]. JOURNAL OF CLINICAL MICROBIOLOGY, 1999, 37 (10) : 3175 - 3178
  • [9] Unexpected high prevalence of secondary bacterial infection in patients with mycetoma
    Ahmed, AOA
    Abugroun, ESAM
    Fahal, AH
    Zijlstra, EE
    van Belkum, A
    Verbrugh, HA
    [J]. JOURNAL OF CLINICAL MICROBIOLOGY, 1998, 36 (03) : 850 - 851
  • [10] Andreu J M, 1986, Med Trop (Mars), V46, P293